In addition, MMP2 inhibitor attenuated the increased proliferation of gastric cancer cells caused by low expression of CDK5RAP3, while the use of MMP2 inhibitor on gastric cancer cells in the normal control group did not show this change (Fig. 6G). The gene discussed is CDK5RAP3; the disease is gastric cancer.